Hemolytic Anemia

As per available reports about 67 journals, 36 Conferences, 15 workshops are presently dedicated exclusively to Hemolytic anemia and about 266282 articles are being published on the current trends in Hemolytic anemia. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to industry management are being carried out. As reported in Coombs Negative Hemolytic Anemia of Unknown Origin in Pregnancy, 2nd edition & Hemolytic Anemia with Fragmented Red Blood Cells Following Vascular Access Grafting for Hemodialysis in a Patient with Chronic Kidney Disease, 5th edition. Hemolytic anemia is a condition in which red blood cells are destroyed and removed from the bloodstream before their normal lifespan is over. Hemolytic Anemia is very common during pregnancy especially in malaria endemic areas. It often associated with Tropical Splenomegaly Syndrome (now commonly known as Hyper-Reactive Malarial Splenomegay), which is an autoimmune phenomenon that follows episodes of malaria in the past. Previously, hemolytic anemia with fragmented red blood cells (RBC) was a major problem in patients treated with hemodialysis, caused by roller pumps responsible for moving blood through the hemodialyzer. Although this problem has been eliminated by technological improvement, hemolytic anemia can still develop in hemodialysis patients due to various causes, such as contamination of the dialysis water, metabolic derangements arising from renal failure, or microangiopathy. On the other hand, hemolytic anemia with fragmented RBC has also been reported in patients who underwent the major cardiovascular surgeries, such as aortic valve replacement or aortofemoral bypass grafting.

The Journal of Blood Disorders & Transfusion is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Hemolytic anemia. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Hematology & Thromboembolic Diseases provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Hemolytic anemia, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences which organizes scientific conferences on Clinical Sciences, Engineering & Applied Sciences, Life Sciences, Medical Sciences, Omics & Management and Pharmaceutical/Chemistry and it is a perfect platform for global networking. 2nd International Conference on Hematology & Blood Disorders (Heamotology-2014) during September 29th - October 01st, 2014 at Baltimore, USA. Heamoyology-2014 mainly aims to create a unique platform to bring experts and researchers in Heamotology & Blood disorders around the world, where they discuss the current research, achievements and advancements in the field.